Abstract Details

Title Clinical Efficacy of AC-1202 (Ketasyn™) in Mild to Moderate Alzheimer’s disease

Topic

Presentation(s) (-)

Poster/Presentation
Number 001

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Lauren Costantini, PhD (Accera, Inc.)	No disclosure on file
	No disclosure on file
	No disclosure on file
Sanee Almas	No disclosure on file
Jose R. Romero, MD (Boston University School of Medicine - Boston Medical Center)	The institution of Dr. Romero has received research support from NIH/NIA.

��ɫ����